Noninvasive neuroimaging is an advanced medical technology that uses imaging techniques such as MRI (magnetic resonance imaging) and CT (computed tomography) to observe an individual's brain without needing to open it up to the skull. It is a fast, noninvasive, and relatively painless way to observe the internal structure and functions of the brain. This medical technology is used to diagnose various neurological conditions, such as Alzheimer's disease, Parkinson's disease, stroke, brain tumours, and traumatic brain injuries. Noninvasive neuroimaging can also provide useful information about the effects of certain conditions on the brain, such as those caused by drug or alcohol use, or environmental factors. Noninvasive neuroimaging involves a simple process whereby the patient is placed in a scanner that uses magnetic fields and radio waves to produce detailed images of the brain. This scan produces a 3-dimensional map of the various structures and functions of the brain such as the cortical lobes, white matter, grey matter, and cerebrospinal fluid, as well as any disease states or injury. This information can be used to identify any structural or functional changes that may be occurring within the brain. Noninvasive neuroimaging has many advantages including a shorter scan time, lower cost, and the ability to track changes in a patient’s brain over time without repeated surgery. This technology is also becoming increasingly sophisticated, with the use of noninvasive techniques such as functional MRI (fMRI) and positron emission tomography (PET) becoming more common in clinical practice.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom